Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,994 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)

NCT01010061

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • San Diego, California, United States
  • Chicago, Illinois, United States
  • Baltimore, Maryland, United States
  • Green Bay, Wisconsin, United States
View all 261 locations
View Trial Details
Completed

CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)

NCT02053610

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • San Diego, California, United States
  • Chicago, Illinois, United States
  • Baltimore, Maryland, United States
  • Green Bay, Wisconsin, United States
View all 261 locations
View Trial Details
Completed

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

NCT03226119

Conditions
Central Nervous System Diseases, Central Nervous System Infections, Deltaretrovirus Infections, +28 more
Locations
  • LABS, Inc. Philadelphia, Pennsylvania, United States
  • Qualtex Laboratories San Antonio, Texas, United States
  • Eastern Virginia Medical School (EVMS) Norfolk, Virginia, United States
View Trial Details
Completed

PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin

NCT00332202

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anchorage, Alaska, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
View all 153 locations
View Trial Details

Related conditions